AP reports a federal policy step on peptides that the health secretary has backed. A big development for the gray-market peptide debate.
Recap by typeshit. Full story at AP News.
A lawyer named Jeff walks through how his side argues Ozempic, Wegovy and other semaglutide drugs may be linked to NAION, a serious form of sudden vision loss.
Stavros Nicolaou of the Pharmaceutical Task Group wants police to act. SAHPRA says it has seized products and opened criminal cases.
The physician group is pushing back on an FDA plan that would open interim access to unapproved peptides, and wants the White House to block it.
Investigators turned up a warehouse of empty pens and a farm building used as a drug factory, as counterfeit weight loss injection sellers grow more organized.
Vox lays out why plans are dropping weight loss drugs after coverage hit about two in three employers, with surveys showing more cuts coming in 2027.
Sources tell CNBC the plan would let pharmacies temporarily compound popular peptides like BPC-157, despite FDA staff safety concerns.
Loading…